Direct oral anticoagulants in very elderly and high-bleeding-risk patients with atrial fibrillation often excluded from oral anticoagulation therapy: a nationwide population-based cohort study.

Y. Go; So-Ryoung Lee; Hyo‐Jeong Ahn; Kyungdo Han; Seil Oh; Professor Gregory Lip

doi:10.1093/europace/euaf230

Shared by

Professor Gregory Lip

University of Liverpool

Direct oral anticoagulants in very elderly and high-bleeding-risk patients with atrial fibrillation often excluded from oral anticoagulation therapy: a nationwide population-based cohort study.

Article 2025 en

Authors

YG
Y. Go
SL
So-Ryoung Lee
HA
Hyo‐Jeong Ahn

Abstract

1 min read

In very elderly, high-bleeding-risk patients with AF, DOACs that were prescribed in usual clinical practice showed better effectiveness and positive net clinical benefit compared with no OAC treatment.

Discussion(0)

No comments yet. Be the first to comment.

Direct oral anticoagulants in very elderly and high-bleeding-risk patients with atrial fibrillation often excluded from oral anticoagulation therapy: a nationwide population-based cohort study.

Abstract

Discussion(0)

Related publications

Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk

Oral anticoagulants in extremely high risk very elderly (&gt;90 years) patients with Atrial Fibrillation

Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk

Abstract 4136743: Current Oral Anticoagulation Use Among Patients With Atrial Fibrillation and Risk Factors Associated With Inadequate Treatments: A Report From a UK Population Cohort Study

Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation

Related publications

Article2021
Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk
Article2021

Article2020
Oral anticoagulants in extremely high risk very elderly (>90 years) patients with Atrial Fibrillation
Article2020

Article2021
Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk
Article2021

Article2024
Abstract 4136743: Current Oral Anticoagulation Use Among Patients With Atrial Fibrillation and Risk Factors Associated With Inadequate Treatments: A Report From a UK Population Cohort Study
Article2024

Article2018
Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation
Article2018

Direct oral anticoagulants in very elderly and high-bleeding-risk patients with atrial fibrillation often excluded from oral anticoagulation therapy: a nationwide population-based cohort study.

Abstract

Discussion(0)

Related publications

Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk

Oral anticoagulants in extremely high risk very elderly (&amp;gt;90 years) patients with Atrial Fibrillation

Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk

Abstract 4136743: Current Oral Anticoagulation Use Among Patients With Atrial Fibrillation and Risk Factors Associated With Inadequate Treatments: A Report From a UK Population Cohort Study

Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation

Oral anticoagulants in extremely high risk very elderly (>90 years) patients with Atrial Fibrillation